Abstract

Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate

Author(s): Trissel Lawrence A, Zhang Yanping

Issue: Sep/Oct 2004 - Topical Treatments in Wound Healing

Page(s): 398-403

Download in electronic PDF format for $75
  • Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Page 1
  • Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Page 2
  • Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Page 3
  • Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Page 4
  • Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Page 5
  • Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Page 6

Abstract

The purpose of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 0.25 mg admixed with dexamethasone (as sodium phosphate) 10 mg or 20 mg in 5% dextrose injection or 0.9% sodium chloride injection in polyvinylchloride minibags, and also admixed with dexamethasone (as sodium phosphate) 3.3 mg in 5% dextrose injection or 0.9% sodium chloride injection in polypropylene syringes, at 4°C stored in the dark for 14 days, and at 23°C exposed to normal laboratory fluorescent light over 48 hours.

Test samples of palonosetron hydrochloride 5 µg/mL with dexamethasone (as sodium phosphate) 0.2 mg/mL and also 0.4 mg/mL were prepared in polyvinylchloride minibags of each infusion solution. Additionally, palonosetron hydrochloride 25 µg/mL with dexamethasone (as sodium phosphate) 0.33 mg/mL in each infusion solution were prepared as 10 mL of test solution in 20-mL polypropylene syringes. Evaluations for physical and chemical stability were performed on samples taken initially and after 1, 3, 7 and 14 days of storage at 4°C and after 1, 4, 24 and 48 hours at 23°C. Physical stability was assessed using visual observation in normal room light and using a high-intensity monodirectional light beam. In addition, turbidity and particle content were measured electronically. Chemical stability of the drug was evaluated by using a stabilityindicating high-performance liquid chromatographic analytical technique.

All samples were physically compatible throughout the study. The solutions remained clear and showed little or no change in particulate burden and haze level. Additionally, little or no loss of palonosetron hydrochloride and dexamethasone occurred in any of the samples at either temperature throughout the entire study period.

Admixtures of palonosetron hydrochloride with dexamethasone sodium phosphate in 5% dextrose injection or in 0.9% sodium chloride injection packaged in polyvinylchloride minibags or in polypropylene syringes were physically compatible and chemically stable for at least 48 hours at room temperature and for 14 days under refrigeration.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2004
Pg. 398-403
Jan/Feb 2017
Pg. 66-75
Nov/Dec 2007
Pg. 520-524
Jan/Feb 2018
Pg. 76-85
Jul/Aug 2015
Pg. 344-347
Jan/Feb 2017
Pg. 76-82
Nov/Dec 2015
Pg. 508
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 323-324
Author(s): Quay Irene, Tan Edward
Jan/Feb 2000
Pg. 66-68
Nov/Dec 1997
Pg. 435-436
Mar/Apr 2008
Pg. 156-160
Mar/Apr 2008
Pg. 170-173
May/Jun 1997
Pg. 208-209
Jan/Feb 2018
Pg. 86-94
Jan/Feb 2009
Pg. 78-80
Mar/Apr 1997
Pg. 132-134
May/Jun 2002
Pg. 226-229
May/Jun 2011
Pg. 190-192
Author(s): Newton David W
Sep/Oct 2017
Pg. 436-439
Jul/Aug 2021
Pg. 330-335